Skip to content
User

Richard Pzena

Pzena Investment Management

Richard Pzena Pfizer Inc stake

total: 584

Pzena Investment Management PFE trades

Total transactions:
45
New positions:
1
Added:
21
Reduced:
23
Held since:
2014 Q4
Held for:
47 quarters
Latest activity:
2026 Q2
According to 2026 Q2 report, Richard Pzena holds 5,958,922 Pfizer Inc (PFE) shares with a market value of roughly $143.49M accounting for 0.42% of the overall portfolio. To date, the estimated cost basis is nearly $32.75 for "buy" trades and estimated average "sell" price is $39.74. Pzena Investment Management first purchased PFE in 2014 Q4, initially acquiring about 2.17M shares. Since the initial investment in Pfizer Inc (PFE), Pzena Investment Management has made 44 more transactions.

How many PFE shares does Richard Pzena currently hold?

According to 2026 Q2 report, Richard Pzena holds 5,958,922 shares of Pfizer Inc (PFE), valued at around $143.49M.

When did Richard Pzena buy Pfizer Inc (PFE)?

Richard Pzena first invested in Pfizer Inc (PFE) in 2014 Q4 at the reported quarter-end price of $31.15 per share.

What's the cost basis of Pzena Investment Management's PFE stake?

The estimated cost basis for Pfizer Inc (PFE) stake is around $32.75 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$32.75
Weighted AVG sell price:
$39.74

Richard Pzena's historical trades in Pfizer Inc

45 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q2
0.42%
5,958,922
$24.08
$143,490,842
+0.57% (+34,030)
+0%
2026 Q1
0.54%
5,924,892
$28.08
$166,370,967
-9.22% (-601,908)
-0.05%
2025 Q4
0.49%
6,526,800
$24.90
$162,517,320
-1.34% (-88,798)
-0.01%
2025 Q3
0.54%
6,615,598
$25.48
$168,565,437
+0.86% (+56,484)
+0%
2025 Q2
0.52%
6,559,114
$24.24
$158,992,924
-7.08% (-499,867)
-0.04%
2025 Q1
0.62%
7,058,981
$25.34
$178,874,579
+1.54% (+107,402)
+0.01%
2024 Q4
0.63%
6,951,579
$26.53
$184,425,391
-4.53% (-330,130)
-0.03%
2024 Q3
0.68%
7,281,709
$28.94
$210,732,659
+0.33% (+24,029)
+0%
2024 Q2
0.71%
7,257,680
$27.98
$203,069,886
-5.38% (-412,765)
-0.04%
2024 Q1
0.73%
7,670,445
$27.75
$212,854,849
+181.64% (+4,947,000)
+0.47%
2023 Q4
0.29%
$28.79
+0.16% (+4,315)
2023 Q3
0.39%
$33.17
-0.20% (-5,481)
2023 Q2
0.43%
$36.68
-0.63% (-17,238)
2023 Q1
0.48%
$40.80
-0.65% (-17,984)
2022 Q4
0.63%
$51.24
-3.82% (-109,519)
2022 Q3
0.62%
$43.76
-3.37% (-100,083)
2022 Q2
0.70%
$52.43
-12.60% (-427,993)
2022 Q1
0.66%
$51.77
-31.96% (-1,595,690)
2021 Q4
1.11%
$59.05
-0.57% (-28,776)
2021 Q3
0.85%
$43.01
+66.39% (+2,003,764)
2021 Q2
0.46%
$39.16
+4.10% (+118,931)
2021 Q1
0.43%
$36.23
+3.17% (+89,086)
2020 Q4
0.49%
$36.81
+2.71% (+74,178)
2020 Q3
0.63%
$36.70
+12.80% (+310,417)
2020 Q2
0.52%
$32.70
-22.95% (-722,584)
2020 Q1
0.78%
$32.64
-0.01% (-340)
2019 Q4
0.58%
$39.18
+0.01% (+313)
2019 Q3
0.62%
$35.93
-0.18% (-5,815)
2019 Q2
0.72%
$43.32
-1.23% (-39,262)
2019 Q1
0.74%
$42.47
-13.60% (-502,831)
2018 Q4
0.94%
$43.65
-16.73% (-742,393)
2018 Q3
0.95%
$44.07
-0.41% (-18,237)
2018 Q2
0.81%
$36.28
+2.04% (+89,174)
2018 Q1
0.79%
$35.49
+0.15% (+6,350)
2017 Q4
0.77%
$36.22
+8.80% (+352,869)
2017 Q3
0.76%
$35.70
+71.86% (+1,676,000)
2017 Q2
0.43%
$33.59
+5.18% (+114,765)
2016 Q4
0.41%
$32.48
-4.81% (-112,127)
2016 Q3
0.48%
$33.87
+6.55% (+143,232)
2016 Q2
0.48%
$35.21
-0.03% (-700)
2016 Q1
0.40%
$29.64
+1.18% (+25,511)
2015 Q4
0.43%
$32.28
+0.08% (+1,775)
2015 Q2
0.41%
$33.53
+0.01% (+200)
2015 Q1
0.42%
$34.79
-0.50% (-10,950)
2014 Q4
0.36%
$31.15
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.